SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-003346
Filing Date
2017-01-20
Accepted
2017-01-20 16:04:46
Documents
4
Period of Report
2017-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-2915_18k.htm 8-K 37597
2 EX-1.1 a17-2915_1ex1d1.htm EX-1.1 263218
3 EX-5.1 a17-2915_1ex5d1.htm EX-5.1 16148
4 GRAPHIC g29151kii001.gif GRAPHIC 4257
  Complete submission text file 0001104659-17-003346.txt   324088
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35619 | Film No.: 17538593
SIC: 2834 Pharmaceutical Preparations